Logo-jnp
J Nephropathol. 2019;8(3): e27. doi: 10.15171/jnp.2019.27

Original Article

Histopathological features of thrombotic microangiopathies in renal biopsies

Miguel Ernandes Neto 1,2 * ORCID, Lucas de Moraes Soler 1, Halita Vieira Gallindo Vasconcelos 1, Daniela Cristina dos Santos 3, Rosa Marlene Viero 3 ORCID, Luis Modelli Gustavo de Andrade 1 ORCID

Cited by CrossRef: 3

1- Hashimoto M, Fujioka Y, Saito A, Saito M, Ubukawa K, Kameoka Y, Kato N, Maruyama S, Honma S, Joh K, Takahashi N. Ravulizumab administration for relapse prevention in atypical hemolytic uremic syndrome with a CFH variant: A case report. Intern Med. 2026; [Crossref]
2- Haydock L, Garneau A, Tremblay L, Yen H, Gao H, Harrisson R, Isenring P. Genetic abnormalities in biopsy-proven, adult-onset hemolytic uremic syndrome and C3 glomerulopathy. J Mol Med. 2022;100(2):269 [Crossref]
3- Blasco M, Guillén E, Quintana L, Garcia-Herrera A, Piñeiro G, Poch E, Carreras E, Campistol J, Diaz-Ricart M, Palomo M. Thrombotic microangiopathies assessment: mind the complement. 2021;14(4):1055 [Crossref]
4- Kovala M, Seppälä M, Kaartinen K, Meri S, Honkanen E, Räisänen-Sokolowski A. Vascular Occlusion in Kidney Biopsy Is Characteristic of Clinically Manifesting Thrombotic Microangiopathy. JCM. 2022;11(11):3124 [Crossref]